View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 15, 2018updated 01 Jun 2021 10:17am

Johnson & Johnson sells LifeScan to Platinum Equity

Global pharmaceutical company Johnson & Johnson has accepted investment firm Plantinum Equity’s offer to acquire LifeScan, its blood glucose monitoring business, for approximately $2.1bn.

By Allie Nawrat

Global pharmaceutical company Johnson & Johnson has accepted investment firm Plantinum Equity’s offer to acquire LifeScan, its blood glucose monitoring business, for approximately $2.1bn.

Platinum Equity’s offer was made in March this year, however, Johnson & Johnson was required to consult with its work councils and the trade unions before it could formally announce the aquisition.

The transaction is expected to close by the end of 2018 following regulatory clearances and other customary conditions.

LifeScan, based in Iverness, Scotland, produces OneTouch products, which include glucose meters, insulin pumps, patches and associated software. Its net revenue reached an estimated $1.5bn in 2017.

Johnson & Johnson acquired LifeScan when it bought Animas Corporation in 2008 and was involved in the development and production of new products, such as OneTouch Ping, an insulin pump connected wirelessly to a blood glucose meter.

Johnson & Johnson consumer medical devices company group chairman Ashley McEvoy said: “LifeScan’s OneTouch blood glucose monitoring products play an important role in the lives of millions of patients living with diabetes, and following a thorough review of all strategic options, we feel confident that the business would have a promising future with Platinum Equity. This initiative is part of our ongoing, disciplined approach to portfolio management to focus on our most promising opportunities to help patients and drive growth.”

The company emphasised in its statements that this sale does not mean it will stop working to produce devices and drugs for those living with diabetes.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology